The relationship between human immunodeficiency virus type 1 (HIV-1) viral RNA and proviral DNA load in vagina and cervix and that found in the plasma and peripheral blood mononuclear cells (PBMC) was investigated in 28 HIV-1 -infected women. Of the patients, 64% had §1 HIV-1 RNA -positive genital sample, while 71% had §1 DNA-positive sample. The higher the cervical HIV load, the more widespread was the virus in the genital tract. A strong correlation was found between viral RNA load in plasma and the genital tract, whereas the association between proviral DNA load in PBMC and the genital tract was less evident. Cervical HIV-1 DNA correlated with a viral RNA load §50,000 copies/mL. Cervical HIV-1 RNA levels ranged from 10% to 100% of the plasma levels. Thus, a continuous transmission risk from untraumatized genital epithelium exists in the majority of HIV-1 -infected women at all stages of infection.
Sexual contact accounts for ú75% of all human immunodeversus plasma and peripheral blood mononuclear cells (PBMC) has not been reported previously. ficiency virus type 1 (HIV-1) infections worldwide [1] . Heterosexual transmission has long been the predominant form of A better understanding of viral shedding in the female genital tract will be important when strategies to reduce both heterotransmission in sub-Saharan Africa and some regions of Asia, and, while homosexual and parenteral transmission has been sexual and mother-to-child transmission of HIV are evaluated and may provide valuable information toward understanding more frequent in industrialized countries, a continuous rise in the frequency of heterosexual transmission is now observed in the pathogenesis of HIV-1 in women. In the present study, HIV-1 DNA and RNA load were assessed in paired vaginal, North America and western Europe, while the number of newly HIV-1 -infected homosexual and bisexual men and intravenous cervical, and plasma and PBMC samples from 28 HIV-infected women. drug users is plateauing or declining [1] . In the United States, the relative number of female AIDS patients has increased 3-fold during the last decade, and presently women have been Materials and Methods estimated to make up 45% of all HIV-infected adults worldwide [1] .
Study subjects. Twenty-eight HIV-1-positive women at-
The epidemiology of HIV-1 transmission provides strong tending the outpatient clinic at the Department of Infectious Disevidence that infectious virus is present in the vaginal and eases, Rigshospitalet (National University Hospital, Copenhagen) agreed to participate. All women answered a questionnaire that cervical secretions of women. Moreover, infectious HIV partiincluded behavioral risk factors as well as medical and gynecologic cles and virus-associated HIV-1 RNA and/or cell-associated history and had a physical and gynecologic examination done durproviral HIV-1 DNA can be isolated from genital secretions ing which blood and vaginal and cervical samples were obtained. [2 -8] . However, the simultaneous detection and quantification Criteria for recruitment included only that the women were HIVof both viral RNA and proviral DNA in vagina and cervix 1-positive, not pregnant, and ú18 years old and did not present with menstrual bleeding on the day of the examination.
Clinical samples. Blood was collected for CD4 and CD8 cell counts, HIV-1 load analysis, and serologic syphilis, cytomegalovi-material from the exocervix and a cytobrush obtained material indicating the absence of substantial PCR inhibitors in the samples (data not shown). from the endocervix (sample B). The endocervical samples were HIV-1 proviruses were quantified in patient DNA by limiting collected by inserting either the swab or the cytobrush into the dilution as described previously [11] . Nested PCR was done over cervical os and rotating it 360Њ. The A and B samples were each the p17 gag coding sequence with the first-round primers gag 1 placed into 2 mL of PBS. Pap smears were generated by use of and gag 3 and the second-round primers gag 2 and gag 4 [12] . material obtained from the B sampling before the rest was placed PCR conditions were optimized to allow single-copy detection of in PBS. No macroscopic bleeding occurred during vaginal and HIV (data not shown). At the single-copy dilution of patient samcervical sample A collection, whereas bleeding was observed in ples, the frequency of positive reactions was 30%-40%. 50% (14/28) of the cervical B samples. The women were also First-and second-round PCR reactions were done in 100 mL evaluated for growth of an array of microorganisms known to and contained patient sample DNA (round 1) Taq). Thirty cycles of amplification were done in both round 1 All genital samples were immediately stored at 4ЊC and proand 2 (GeneAmp PCR System 9600). Each cycle consisted of 1 cessed within 60 min. To process, the cytobrush and swabs were min at 94ЊC, 30 s at 57ЊC, and 45 s at 72ЊC. The last cycle was vortexed in a tube with PBS, rotated 360Њ against the inside of the followed by a 5-min incubation at 72ЊC. tube to extract residual fluid, and then discarded. Samples were PCR reactions derived from presumed single-copy templates subsequently centrifuged at 180 g for 10 min to collect cells, and were sequenced by use of virus from the vagina, cervix, and PBMC the supernatant was transferred to a new tube and subsequently from each patient to verify their origin from the same patient and centrifuged at 1500 g for 10 min to remove residual cells. Cervical thereby eliminate the possibility of sample mix-up or contaminacells and supernatants were stored at 080ЊC.
tion during PCR (DyeDeoxy Terminators; Applied Biosystems, Ten swabs and cytobrushes were weighed before and after abFoster City). Assignment of sequences to subtypes was based on sorption of secretions. As the mean amounts of secretions absorbed the phylogenetic affinities of the Danish-derived sequences to other by the swabs and cytobrushes were 0.17 mL (range, 0.14-0. 20) sequences of known subtypes and by comparison with 50% conand 0.22 mL (range, 0.18-0.27), respectively, the dilution in the sensus sequences from the Los Alamos HIV Sequence Database vaginal and cervical A tubes was estimated to be 7-fold, and that (Iversen AKN, Learn GH, Mullins JI, unpublished data). in the cervical B tubes was estimated to be 6-fold.
Statistical analysis. HIV RNA and proviral DNA levels were RNA polymerase chain reaction (PCR). The HIV-1 RNA load transformed into log 10 values before analysis. Comparisons of prowas estimated for the gag gene in plasma, vaginal, and cervical virus or virus load means between groups of patients were made A and B supernatants by use of the Amplicor HIV Monitor kit by one-way analysis of variance, and comparisons of two means (Roche Diagnostic Systems, Nutley, NJ) according to the manufacwere made by Student's t test. Spearman's rank correlation was turer's recommendations. According to the manufacturer, the coefused to examine linear associations. Contingency tables were anaficient of variation of the assay is 30%-40%, resulting in 2-fold lyzed by either the x 2 or Fisher's exact test depending on sample differences in virus load being within the range of assay variation.
size. The sensitivity of the HIV Monitor test on non-B HIV subtypes has been evaluated by the manufacturer on a limited number of isolates (2-5 isolates/subtype). The sensitivity of detection relative
Results
to HIV subtype B was found to be as follows: subtype A, 0-15%; subtype C, 50%-97%; subtype D, 90%-130%; subtype G, 75%-Clinical data. The characteristics of the study population 5 cells) was tested fluids. The adjusted data must be viewed as rough approximations of the actual RNA level, as the amount of material picked from each negative genital sample. As with viral RNA, HIV DNA detection was most frequent in cervical B specimens (19 up by a swab depends on the amount of secretion present, which varies throughout the menstrual cycle [13] .
[68%]), whereas only a subset of these positive women had positive cervical A samples (10 [36%], plus 1 whose cervical Three patient groups were created on the basis of detection of viral RNA in the cervix and vagina and analyzed with respect A sample only was positive) and vaginal specimens (8 [29%]) (table 2). The primers used for estimation of the HIV proviral to plasma virus load ( figure 1A) . The first group (group V 1 ), which included patients with HIV-1 RNA -positive vaginal and DNA load are situated in an area of the gag gene that is very conserved across subtypes [12] , suggesting that most HIV cervical samples, had the highest plasma RNA load. The second † 1 Å first half, 2 Å second half, M Å mid-cycle, ME Å menopause, HO Å hormone therapy, OCP Å oral contraceptive pills. No menstrual bleeding was evident. ‡ ZDV Å zidovudine, ddI Å didanosine, CT Å clinical trial (either CT1 Å ZDV, ddI with or without protease inhibtor (PRI); CT2 Å ZDV / zalcitabine, ZDV / PRI, or ZDV / zalcitabine / PRI; CT3 Å ZDV, ZDV / lamivudine, or ZDV / lamivudine / loviride; CT4 Å ZDV / lamivudine with or without PRI.
sequences belonging to non-B subtypes will be efficiently amsamples) and analyzed with respect to PBMC provirus burden ( figure 2A ). The V 2 group included patients with DNA-positive plified by use of these primers. To eliminate the possibility of cross-sample contamination contributing to the positive signals, vaginal and cervical samples, and this group had the highest PBMC DNA burden. The C 2 group included patients with posiwe sequenced one randomly chosen positive PCR reaction from each tissue from each patient. All sequences from the same tive cervical and negative vaginal samples, and in contrast to the pattern observed for RNA positivity, this group had a patient were found to be similar, yet distinct from sequences from other patients (data not shown).
PBMC proviral DNA load slightly lower than that of N 2 group, with all negative genital DNA samples. A significant difference The number of HIV-1 DNA -positive specimens among cervical A samples was significantly lower than among cervical in viral DNA load was found only between the V 2 and C 2 groups, in both blood (P õ .005) (figure 2A) and cervix (P õ B samples (P Å .025), possibly because of the likely presence of more epithelium and some stroma, and hence a greater num-.001) (figure 2B). A significant correlation was detected between the level of ber of infected cells, in B samples. The presence of blood in some of the cervical B samples (50%, 14/28) did not signifiprovirus in cervical A and B samples (r s Å .67, P õ .001), between cervical A and vaginal (r s Å .75, P õ .001) or PBMC cantly affect the HIV proviral status of the samples, in accordance with a prior study [14] .
(r s Å .55, P Å .005) samples, and between vaginal and cervical B (r s Å .74, P õ .001) or PBMC (r s Å .53, P Å .006) samples. The patients were again placed into 3 groups on the basis of the prevalence of HIV-1 provirus in vaginal and cervical No significant association existed between cervical B and PBMC samples. samples (here grouping those with positive cervical A and B between high plasma virus load and the presence of HIV DNA in cervical B samples (P Å .06), possibly because of the substantial proportion of women with positive cervical B samples and plasma virus loads õ50,000 copies/mL.
Discussion
We were able to detect HIV-1 RNA in the genital tracts of 64% of the HIV-positive women examined, with a strong association between genital and plasma viral RNA load. Furthermore, the higher the plasma RNA load, the more widespread the detection of virus in the three types of genital tract samples. Our results are supported by one recent study [3] and are in contrast to another [15] . However, the sensitivity of the reverse transcription -PCR assay used in the latter study seems to be substantially lower than that we used, and the processing they used for the genital samples could result in more RNA breakdown (incubation for 15 -20 min at 37ЊC), all of which could contribute to the divergent results. . Group V 1 (n Å 8): geometric mean titer (GMT) Å 85,065 copies/mL of plasma; group C 1 (n Å 10): GMT Å 9022 copies/mL of plasma; group N 1 (n Å 10): GMT Å 1598 copies/mL of plasma. B, Mean cervical HIV-1 RNA load in V 1 and C 1 groups. Group V 1 (n Å 8): GMT Å 31,045 copies/mL of cervical secretions; group C 1 (n Å 10): GMT Å 1656 copies/mL of cervical secretions.
The variation in HIV-1 DNA levels could not be explained by differences in antiretroviral therapy, phase of menstrual cycle, cytologic abnormalities, or genital infections. For example, 74% (14/19) of the women with DNA-positive genital samples had genital infections, compared with 67% (6/9) of women with DNA-negative samples.
Relationship between detection of HIV-1 RNA and DNA. A total of 57% (16/28) of the women were found to have detectable HIV-1 RNA and DNA in their genital samples; 18% (5/ 28) were either HIV-1 RNA -or DNA -positive, whereas 25% (7/28) were negative for both. The association between the presence or absence of both HIV RNA and DNA in the cervix was significant (P õ .01). The degree of association may be underestimated, as the primers used for detection of HIV RNA and DNA may differ in the level of sensitivity of detection of non-B HIV subtypes. No significant differences were found In contrast, only a borderline significant association was found that much of the genital virus may originate from continuous and childbirth, could result in an increase in the amount of cell-free virus in the genital region as well as enhance the local transudation of plasma, which is known to make up part of the normal genital secretions [16] . HIV-1 RNA was found more infection of CD4 cells. Since in our study, nearly two-thirds of HIV-positive women frequently and in higher concentrations in the cervix than in the vagina, but in women carrying virus at both sites, the total carried detectable genital virus loads, our data and the finding of the significant role of oral exposure in transmission of HIV amount of virus in the vagina could surpass that of the cervix because of the larger surface area of the vagina.
[19] and simian immunodeficiency virus [20] raise further concerns for the HIV transmission risk during oral sex with Of the subjects, 71% had detectable HIV-1 DNA in their genital regions, slightly more than twice that found in most women. Moreover, as some asymptomatic patients were found to harbor virus in their genital region in amounts similar to other studies [3, 4, 13] . A possible explanation is that we examined greater amounts of DNA (on average, 2.4 mg) those found in AIDS patients, our data underscore the importance of caution during sexual contact at all stages of infection than most other studies and were therefore able to score provirus loads õ1 copy/mg of DNA (32%, 8/25 ). In addition, and disease. some other studies used only swab samples and reached detection rates comparable to the detection rate found in our cervical A swab samples (11/28, 39%). Thus, our sampling
